First Time Loading...

Intercept Pharmaceuticals Inc
NASDAQ:ICPT

Watchlist Manager
Intercept Pharmaceuticals Inc Logo
Intercept Pharmaceuticals Inc
NASDAQ:ICPT
Watchlist
Price: 19 USD Market Closed
Updated: May 15, 2024

Intercept Pharmaceuticals Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Intercept Pharmaceuticals Inc
Pre-Tax Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Intercept Pharmaceuticals Inc
NASDAQ:ICPT
Pre-Tax Income
-$57.5m
CAGR 3-Years
44%
CAGR 5-Years
30%
CAGR 10-Years
4%
Abbvie Inc
NYSE:ABBV
Pre-Tax Income
$6.3B
CAGR 3-Years
23%
CAGR 5-Years
4%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Pre-Tax Income
$1.1B
CAGR 3-Years
-18%
CAGR 5-Years
-33%
CAGR 10-Years
-16%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$4.3B
CAGR 3-Years
-18%
CAGR 5-Years
-14%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Pre-Tax Income
$4.4B
CAGR 3-Years
12%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Pre-Tax Income
$4B
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
18%

See Also

What is Intercept Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
-57.5m USD

Based on the financial report for Sep 30, 2023, Intercept Pharmaceuticals Inc's Pre-Tax Income amounts to -57.5m USD.

What is Intercept Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
4%

Over the last year, the Pre-Tax Income growth was 72%. The average annual Pre-Tax Income growth rates for Intercept Pharmaceuticals Inc have been 44% over the past three years , 30% over the past five years , and 4% over the past ten years .